Mega Lifesciences PCL operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mega Lifesciences PCL with three other
pharmaceutical manufacturers in Asia:
Guangdong Zhongsheng Pharmaceutical Co Ltd
sales of 2.53 billion Chinese Renmimbi [US$373.83 million]
of which 90%
was Medicine Manufacture),
Jiang Zhong Pharmaceutical Co Ltd
(2.45 billion Chinese Renmimbi [US$361.64 million]
of which 99%
was Medical Industry), and
Eiken Chemical Co., Ltd.
based in JAPAN
(35.76 billion Japanese Yen [US$342.59 million]
of which 56%
was Immunoserology Test Agent).
Mega Lifesciences PCL reported sales of 11.13 billion Thai Bahts (US$357.93 million)
December of 2019.
increase of 7.6%
versus 2018, when the company's sales were 10.34 billion Thai Bahts .
Sales at Mega Lifesciences PCL have increased during each of the previous five years
(and since 2014, sales have increased a total of 44%).
Sales of Distribution saw an increase
that was more than double the company's growth rate: sales were up
17.1% in 2019, from
4.45 billion Thai Bahts to 5.22 billion Thai Bahts .
Not all segments of Mega Lifesciences PCL experienced an increase in sales in 2019:
sales of Oem fell 15.4% to 239.40 million Thai Bahts .
(However, this segment's sales were only a very small portion of the company's overall sales).